Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | SLC1A5 | Q15758 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | KMO | O15229 | 2/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.39 |
| ▸ | S100A9 | P06702 | 1/20 | 0.39 |
| ▸ | PGK1 | P00558 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL236764 | 1.00 | CYP3A4 (0.46) | CYP3A4TSHRSLC1A5CA1CA2 | |
| SCHEMBL11298945 | 0.86 | CYP3A4 (0.45) | CYP3A4TSHRSLC1A5CA1CA2 | |
| SCHEMBL22815715 | 0.85 | KMO (0.47) | CYP3A4TSHRSLC1A5KMOGRIN2B | |
| SCHEMBL1555931 | 0.84 | CYP3A4 (0.46) | CYP3A4TSHRSLC1A5CA1CA2 | |
| SCHEMBL9447561 | 0.83 | MEN1 (0.44) | CYP3A4TSHRSLC1A5CA1CA2 | |
| SCHEMBL27483990 | 0.83 | CYP3A4 (0.42) | CYP3A4TSHRSLC1A5CA1CA2 | |
| SCHEMBL3802892 | 0.82 | CYP3A4 (0.48) | CYP3A4TSHRCA1CA2MRGPRX4 | |
| SCHEMBL9367414 | 0.81 | GAA (0.40) | CYP3A4TSHRSCN9AALDH1A1ALOX15 | |
| SCHEMBL28351619 | 0.80 | MEN1 (0.42) | CYP3A4TSHRSLC1A5CA1CA2 | |
| SCHEMBL11307249 | 0.80 | CYP3A4 (0.39) | CYP3A4TSHRSLC1A5CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116768824-B | Imide azole heterocyclic compound and application thereof | 华南农业大学 | 2025-06-10 | — | — | CN | disclosed |
| CN-119977850-A | Urea derivative containing aryl sulfonamide structure, and preparation method and application thereof | 沈阳药科大学 | 2025-05-13 | — | — | CN | disclosed |
| CN-112898196-B | Potent soluble epoxide hydrolase inhibitors | 艾科西斯有限责任公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-119060060-A | Imidazole-containing ALK2 kinase inhibitors | 拜奥克里斯特制药公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-110913855-B | Imidazole-containing ALK2 kinase inhibitors | 拜奥克里斯特制药公司 | 2024-09-03 | — | — | CN | disclosed |
| WO-2024129780-A1 | BENZIMIDAZOLE DERIVATIVES AS GPX4 INHIBITORS | SONATA THERAPEUTICS, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| CN-112074511-B | Substituted benzodiazoles and their use in therapy | 托马斯·黑勒戴药物研究基金会 | 2024-04-26 | — | — | CN | disclosed |
| CN-111170991-B | Antiproliferative compounds and methods of synthesis thereof | 细胞基因公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116947740-A | Hydroxamic acid compound containing urea structure, preparation method thereof and application of hydroxamic acid compound in preparation of HDAC and sEH dual inhibitors | 沈阳药科大学 | 2023-10-27 | — | — | CN | disclosed |
| CN-116768824-A | Imide azole heterocyclic compound and application thereof | 华南农业大学 | 2023-09-19 | — | — | CN | disclosed |
| CN-116199636-A | 2, 4-disubstituted pyrimidine derivative of targeted tumor immunity kinase, preparation method and application thereof | 杭州医学院 | 2023-06-02 | — | — | CN | disclosed |
| WO-2022266426-A1 | 6-(HETEROCYCLOALKYL-OXY)-QUINAZOLINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2022-12-22 | — | — | WO | disclosed |